相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32
Isabel Pimentel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Hormone therapy for ovarian cancer: Emphasis on mechanisms and applications (Review)
Hongyi Li et al.
ONCOLOGY REPORTS (2021)
Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study
Pamela T. Soliman et al.
CLINICAL CANCER RESEARCH (2020)
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
Saman Bahrambeigi et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study
Mayu Hosio et al.
ACTA ONCOLOGICA (2020)
Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Min Wei et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Metformin and Breast Cancer: Molecular Targets
J. Faria et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2019)
No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies
Yongbo Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses
Qiao Wen et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2019)
Novel application of metformin combined with targeted drugs on anticancer treatment
Jun Deng et al.
CANCER SCIENCE (2019)
The effect of metformin on biomarkers and survivals for breast cancer- a systematic review and meta-analysis of randomized clinical trials
Zhi-Jiang Zhang et al.
PHARMACOLOGICAL RESEARCH (2019)
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
Sunghwan Suh et al.
DIABETES & METABOLISM JOURNAL (2019)
Association of Metformin with Breast Cancer Incidence and Mortality in Patients with Type II Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis
Grace H. Tang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)
Anti-Cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer
Masoumeh Kheirandish et al.
CURRENT DRUG METABOLISM (2018)
The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer
C. M. Nagle et al.
GYNECOLOGIC ONCOLOGY (2018)
Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies
Dongyu Zhang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Nicole E. Scharping et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Effects of metformin on endometrial cancer: Systematic review and meta-analysis
Cinthia G. Meireles et al.
GYNECOLOGIC ONCOLOGY (2017)
Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer A retrospective study
Shan-Bing Wang et al.
MEDICINE (2017)
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Vanita R. Aroda et al.
DIABETOLOGIA (2017)
Repurposing metformin for the prevention of cancer and cancer recurrence
Brandy M. Heckman-Stoddard et al.
DIABETOLOGIA (2017)
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
C. Coyle et al.
ANNALS OF ONCOLOGY (2016)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Activation of AMP-activated Protein Kinase by Metformin Induces Protein Acetylation in Prostate and Ovarian Cancer Cells
Luciano Galdieri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Diabetes mellitus and prognosis in women with breast cancer A systematic review and meta-analysis
Xiao-Bo Zhao et al.
MEDICINE (2016)
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
Ernst Lengyel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Metformin in Cancer Treatment and Prevention
Daniel R. Morales et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells
Jaslyn Sian-Siu Soo et al.
APOPTOSIS (2015)
Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44+CD117+ ovarian cancer stem cells
Rongrong Zhang et al.
STEM CELL RESEARCH & THERAPY (2015)
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Z. -J. Zhang et al.
DIABETES OBESITY & METABOLISM (2014)
Diabetes mellitus and ovarian cancer: More complex than just increasing risk
Monjri M. Shah et al.
GYNECOLOGIC ONCOLOGY (2014)
Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
Ya Xie et al.
MOLECULAR MEDICINE REPORTS (2014)
Metformin intake is associated with better survival in ovarian cancer A Case-Control Study
Sanjeev Kumar et al.
CANCER (2013)
Metformin Decreases Circulating Androgen and Estrogen Levels in Nondiabetic Women With Breast Cancer
Carlo Campagnoli et al.
CLINICAL BREAST CANCER (2013)
Diabetes Mellitus and Ovarian Cancer Risk A Systematic Review and Meta-Analysis of Observational Studies
Jung-Yun Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners
Rive Sarfstein et al.
PLOS ONE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Metformin targets ovarian cancer stem cells in vitro and in vivo
Jessica J. Shank et al.
GYNECOLOGIC ONCOLOGY (2012)
Time-window Bias in Case-control Studies
Samy Suissa et al.
EPIDEMIOLOGY (2011)
The impact of diabetes on survival in women with ovarian cancer
Arvind Bakhru et al.
GYNECOLOGIC ONCOLOGY (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men.
Eric L. Ding et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Multiple imputation of missing values: Further update of ice, with an emphasis an categorical variables
Patrick Royston
STATA JOURNAL (2009)
Reducing bias through directed acyclic graphs
Ian Shrier et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
分享论文
